Your browser doesn't support javascript.
loading
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma.
Merz, Maximilian; Hielscher, Thomas; Mai, Elias Karl; Seckinger, Anja; Hose, Dirk; Jauch, Anna; Sauer, Sandra; Luntz, Steffen; Bertsch, Uta; Raab, Marc S; Neben, Kai; Salwender, Hans; Blau, Igor W; Lindemann, Hans-Walter; Dürig, Jan; Scheid, Christof; Haenel, Mathias; Weisel, Katja; Weber, Tim; Delorme, Stefan; Goldschmidt, Hartmut; Hillengass, Jens.
Afiliação
  • Merz M; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany. maximilian.merz@med.uni-heidelberg.de.
  • Hielscher T; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. maximilian.merz@med.uni-heidelberg.de.
  • Mai EK; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Seckinger A; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Hose D; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Jauch A; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Sauer S; Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.
  • Luntz S; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Bertsch U; Coordination Center for Clinical Trials, University Hospital Heidelberg, Heidelberg, Germany.
  • Raab MS; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Neben K; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Salwender H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Blau IW; Max-Eder Research Group Experimental therapies for hematologic malignancies, DKFZ, Heidelberg, Germany.
  • Lindemann HW; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Dürig J; Asklepios Klinik und St. Georg, Altona, Hamburg, Germany.
  • Scheid C; Department of Internal Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany.
  • Haenel M; Department of Hematology and Oncology, Kath. Krankenhaus Hagen gem. GmbH - St.-Marien-Hospital, Hagen, Germany.
  • Weisel K; Department of Hematology and Oncology, University Hospital of Essen, Essen, Germany.
  • Weber T; Department of Internal Medicine I, University of Cologne, Cologne, Germany.
  • Delorme S; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
  • Goldschmidt H; II. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Hillengass J; Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Blood Cancer J ; 9(9): 71, 2019 08 27.
Article em En | MEDLINE | ID: mdl-31455768
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article